Rabies vaccine trial for people aged 10 to 60
Part of Infections clinical trials.
This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 60 years old.
- You have not had a rabies vaccine or rabies immune treatment before.
- You have not been bitten or scratched by an animal that could carry rabies recently.
- You do not have serious health problems like uncontrolled high blood pressure, immune system disorders, or cancer.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new freeze-dried rabies vaccine grown in human cells. It aims to confirm the vaccine is safe and works well for people aged 10 to 60 who have not been vaccinated against rabies before and have not been recently bitten by a rabid animal. By joining, you help ensure that a reliable vaccine is available to protect against this serious disease.
This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.
This study tests a new rabies vaccine given before any exposure to the virus, to help prevent infection. It aims to see if the vaccine is safe and creates a strong immune response in healthy people.
This study tests whether a new experimental rabies vaccine, when given with the standard rabies vaccine, is safe and helps the body build a strong immune response. It aims to find a better way to protect against rabies.
This study compares two ways of giving the rabies vaccine—one injected just under the skin and one injected into the muscle—to see which is safer and more effective. It may help make rabies prevention easier and less painful.
This trial provides access to an experimental medicine (SYN023) for people with rabies who have no other options. It aims to treat the infection, but since there is no standard cure, this is a special program for urgent cases.
Hear when a new Rabies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.